SRX Global Inc. completed an additional closing of a private placement under a Securities Purchase Agreement dated March 16, 2026. On July 27, 2026, the company issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants to purchase common stock to accredited investors. The transaction generated approximately $3.472 million in aggregate cash proceeds. The warrant count reflects the company's 60-for-1 reverse stock split, which became effective on July 2, 2026. This financing brings total proceeds under the agreement to approximately $8.0 million. SRX Global Inc. operates in the healthcare sector, specifically focusing on digital health solutions and medical technology.
